| Literature DB >> 35990290 |
Selda Gucek Haciyanli1, Serkan Karaisli1, Beste Suataman1, Furkan Karahan1, Mehmet Haciyanli1.
Abstract
Objectives: Concomitant thyroid disease affects almost half of the primary hyperparathyroidism (PHPT) patients. Pre-operative evaluation of the thyroid gland for the early diagnosis of thyroid carcinoma is essential in PHPT patients. Herein, we aim to investigate the clinicopathologic features that affect the type and extent of surgery in patients having PHPT and concomitant thyroid disease but especially thyroid cancer.Entities:
Keywords: Carcinoma; parathyroidectomy; primary hyperparathyroidism; thyroid; thyroidectomy
Year: 2022 PMID: 35990290 PMCID: PMC9350048 DOI: 10.14744/SEMB.2022.36418
Source DB: PubMed Journal: Sisli Etfal Hastan Tip Bul ISSN: 1302-7123
Thyroidectomy indications in the study group
| Indication | n (%) |
|---|---|
| Nodular goiter | 58 (69) |
| Hyperthyroidism | 8 (9.5) |
| Toxic adenoma | 2 (2.4) |
| Retrosternal goiter | 3 (3.6) |
| Thyroid cancer | 5 (5.9) |
| Indeterminate cytology | 8 (9.5) |
| Total | 84 (100) |
Figure 1Diagram of surgical and histopathological features of the groups.
Comparison of demographic and clinical characteristics of the groups
| Group 1 (n=55) | Group 2 (n=29) n (%) | All patients (n=84) | p | |
|---|---|---|---|---|
| Gender | 0.712 | |||
| Female | 50 (90.9%) | 25 (86.2%) | 75 (89.3%) | |
| Male | 5 (9.1%) | 4 (13.8%) | 9 (10.7%) | |
| Age | 58.71±11.16 | 56.1±13.29 | 57.81±11.92 | 0.344 |
| Duration of hospital stay (days) | 1.25±0.67 | 1.28±0.99 | 1.26±0.79 | 0.908 |
| Pre-operative parathormone | 270.76±226.71 | 448.07±647.84 | 331.98±426.86 | 0.261 |
| Pre-operative calcium | 11.4±1.25 | 11.72±1.59 | 11.51±1.38 | 0.315 |
| Pre-operative phosphorus | 2.75±0.52 | 2.51±0.44 | 2.67±0.51 | 0.041 |
| Presentation of primary hyperparathyroidism | 0.48 | |||
| Symptomatic | 11 (20%) | 4 (13.8%) | 15 (17.9%) | |
| Asymptomatic | 44 (80%) | 25 (86.2%) | 69 (82.1%) | |
| Pathological parathyroid gland side | 0.340 | |||
| Right | 29 (52.7%) | 11 (37.9%) | 40 (47.6%) | |
| Left | 23 (41.8%) | 17 (58.6%) | 40 (47.6%) | |
| Bilateral | 3 (5.5%) | 1 (3.4%) | 4 (4.8%) | |
| Pathological parathyroid gland location | 0.704 | |||
| Upper | 21 (38.2%) | 13 (44.8%) | 34 (40.5%) | |
| Lower | 30 (54.5%) | 15 (51.7%) | 45 (53.6%) | |
| Combined | 4 (7.3%) | 1 (3.4%) | 5 (5.9%) | |
| Operation | 0.001 | |||
| Parathyroidectomy + Lobectomy | 35 (63.6%) | 7 (24.1%) | 42 (50%) | |
| Parathyroidectomy + Total thyroidectomy | 20 (36.4%) | 22 (75.9%) | 42 (50%) | |
| Parathyroid pathology | 0.863 | |||
| Single adenoma | 51 (92.7%) | 27 (93.1%) | 78 (92.9%) | |
| Double adenoma | 1 (1.8%) | 1 (3.4%) | 2 (2.4%) | |
| Triple adenoma | 1 (1.8%) | 0 | 1 (1.2%) | |
| Hyperplasia | 2 (3.7%) | 1 (3.4%) | 3 (3.5%) | |
| Complication | 0.015 | |||
| No | 50 (90.9%) | 20 (69%) | 70 (83.3%) | |
| Yes | 5 (9.1%) | 9 (31%) | 14 (16.7%) | |
| Transient hypocalcemia | 4 (7.3%) | 8 (27.6%) | 12 (14.2%) | |
| Permanent hypocalcemia | 0 | 1 (3.4%) | 1 (1.2%) | |
| Persistence | 1 (1.8%) | 0 | 1 (1.2%) | |
| Permanent complication | 0.345 | |||
| Yes | 0 | 1 (3.4%) | 1 (1.2%) | |
| No | 55 (100%) | 28 (96.6%) | 83 (98.8%) |
Figure 2Diagram of the results of fine-needle aspiration biopsy in the study group.